Company / Debt per Share
Foghorn Therapeutics Inc. Debt per Share History
FY2020-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Debt per Share
$0.53
FY2021
5-year range
$0.53 / $0.53
FY2020-FY2021
Trend
-86.8%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
0.53 in FY2021.
Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2021, debt per share decreased 86.8% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score -1.20 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | $0.53 | -86.8% |
| FY2020 | $4.04 | - |
As of FY2021 · SEC 10-K · Updated Jun 24, 2026